| Sr No. |
|
Additional disclosure of related
party transactions - applicable only in case the related party transaction relates to loans,
inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary.
These details need to be disclosed only once, during the reporting period when such transaction was
undertaken. |
| Details of the party (listed entity/subsidiary) entering into the transaction |
Details of the counterparty |
Type of related party transaction |
Details of other related party transaction |
Value of the related party transaction as approved by the audit committee |
Remarks on approval by audit committee |
Value of the related party transaction ratified by the audit committee |
Date of Audit Committee Meeting where the ratification was approved |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments |
Notes |
| Name |
PAN |
Name |
PAN |
Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance |
Closing balance |
Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Details of other indebtedness |
Cost |
Tenure |
Nature (loan/ advance/ intercorporate deposit/ investment ) |
Interest Rate (%) |
Tenure |
Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
2,846.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 2 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
1.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
7,491.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
15.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
415.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
2,819.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
5,339.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
12.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Distribution s.r.o.Czech Republic |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
8,258.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Distribution s.r.o.Czech Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
105.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 11 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Distribution s.r.o.Czech Republic |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
14,742.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 12 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Distribution s.r.o.Czech Republic |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
8.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 13 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Distribution s.r.o.Czech Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
26.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 14 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
1,365.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 15 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Purchase of fixed assets |
|
|
- |
|
|
169.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 16 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
63.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 17 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
8,592.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 18 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
520.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 19 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
601.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 20 |
Glenmark Pharmaceuticals s.r.o. |
|
Viso Farmaceutica S.L.U. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
4,280.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 21 |
Glenmark Pharmaceuticals s.r.o. |
|
Viso Farmaceutica S.L.U. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
4.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 22 |
Glenmark Pharmaceuticals s.r.o. |
|
Viso Farmaceutica S.L.U. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
159.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 23 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
79.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 24 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
6,411.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 25 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
52.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 26 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Nordics SE |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
283.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 27 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Nordics SE |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
6,537.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 28 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Nordics SE |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
219.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 29 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
488.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 30 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Purchase of fixed assets |
|
|
- |
|
|
774.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 31 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
13,922.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 32 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
288.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 33 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Purchase of fixed assets |
|
|
- |
|
|
18.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 34 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
433.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 35 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1,017.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 36 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
44.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 37 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
60.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 38 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
110.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 39 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
1.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 40 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
5.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 41 |
Glenmark Pharmaceuticals SK, s.r.o. |
|
Glenmark Pharmaceuticals Distributions S.R.O., Czech |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
287.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 42 |
Glenmark Pharmaceuticals SK, s.r.o. |
|
Glenmark Pharmaceuticals Distributions S.R.O., Czech |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
53.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 43 |
Glenmark Pharmaceuticals Sp. z o.o. |
|
Glenmark Pharmaceuticals Distributor s.r.o. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
3.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 44 |
Glenmark Pharmaceuticals Sp. z o.o. |
|
Glenmark Pharmaceuticals Distributor s.r.o. |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
490.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 45 |
Glenmark Pharmaceuticals Sp. z o.o. |
|
Glenmark Pharmaceuticals Distributor s.r.o. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 46 |
Glenmark Pharmaceuticals Sp. z o.o. |
|
Glenmark Pharmaceuticals UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
4.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 47 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses paid on behalf of others |
|
- |
|
|
0.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 48 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
GLENMARK FARMACĆUTICA, S.L. (Spain) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 49 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Arzneimittel GmbH |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 50 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharma Nordic (SE) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 51 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Arzneimittel GmbH AT |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 52 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
Viso Farmaceutica S.L.U., Spain |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Incurred on behalf |
|
- |
|
|
15.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 53 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
Glenmark Pharmaceuticals B.V., Netherlands |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
307.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 54 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
Glenmark Pharmaceuticals B.V., Netherlands |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Incurred on behalf |
|
- |
|
|
27.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 55 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
Glenmark Pharmaceuticals B.V., Netherlands |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Incurred by |
|
- |
|
|
9.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 56 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
Glenmark Nordics SE |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Incurred on behalf |
|
- |
|
|
19.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 57 |
Glenmark Pharmaceuticals Europe Limited, UK |
|
GLENMARK ARZNEIMITTEL GMBH - Austria |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Incurred on behalf |
|
- |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 58 |
Glenmark Arzneimittel GmbH |
|
Glenmark Pharmaceuticals Europe Limited -U.K. |
|
Wholly Owned Subsidiary |
Any other transaction |
Interest Loan |
|
- |
|
|
150.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 59 |
Glenmark Arzneimittel GmbH |
|
Glenmark Pharmaceuticals Europe Limited -U.K. |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
74.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 60 |
Glenmark Ukraine LLC |
|
GLENMARK ARZNEIMITTEL GMBH - Austria |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
36.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 61 |
Glenmark Italy - Sintesy Pharma |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Paid by others on our behalf |
|
- |
|
|
129.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 62 |
Glenmark Italy - Sintesy Pharma |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Interest on loan |
|
- |
|
|
38.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 63 |
Glenmark Arzneimittel GmbH |
|
Sintesy Pharma SrL |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
151.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 64 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Ltd.-Mexico |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
196.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 65 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Ltd. -Peru |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
85.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 66 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Any other transaction |
Cross charge |
|
- |
|
|
1.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 67 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Ecuador |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
43.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 68 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Generics S.A |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
999.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 69 |
Glenmark Generics S.A |
|
Glenmark Pharmaceuticals Kenya |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
13.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 70 |
Glenmark Generics S.A |
|
Glenmark Pharmaceuticals Mexico |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
519.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 71 |
Glenmark Generics S.A |
|
Glenmark Pharmaceuticals Peru |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
41.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 72 |
Glenmark Generics S.A |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
153.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 73 |
Glenmark Pharmaceuticals Kenya Limited |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
5.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 74 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 75 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1.60 |
65.60 |
|
|
|
|
|
|
|
|
|
|
| 76 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
3.90 |
2.50 |
|
|
|
|
|
|
|
|
|
|
| 77 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
15.90 |
242.00 |
|
|
|
|
|
|
|
|
|
|
| 78 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Ukraine LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 79 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals s.r.o. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
812.00 |
1,355.80 |
|
|
|
|
|
|
|
|
|
|
| 80 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharma Nordic (SE) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 81 |
Glenmark Pharmaceuticals Distribution s.r.o. |
|
Glenmark Pharmaceuticals s.r.o. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,933.00 |
5,766.40 |
|
|
|
|
|
|
|
|
|
|
| 82 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
618.80 |
1,573.10 |
|
|
|
|
|
|
|
|
|
|
| 83 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
4,846.90 |
5,040.90 |
|
|
|
|
|
|
|
|
|
|
| 84 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
1,345.20 |
1,227.00 |
|
|
|
|
|
|
|
|
|
|
| 85 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
5,939.80 |
4,796.40 |
|
|
|
|
|
|
|
|
|
|
| 86 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
483.90 |
1,836.30 |
|
|
|
|
|
|
|
|
|
|
| 87 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals Europe Ltd, UK |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
685.90 |
2,718.00 |
|
|
|
|
|
|
|
|
|
|
| 88 |
Glenmark Pharmaceuticals s.r.o. |
|
Viso Farmaceutica S.L.U., Spain |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
4,125.20 |
4,092.20 |
|
|
|
|
|
|
|
|
|
|
| 89 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
39.40 |
39.00 |
|
|
|
|
|
|
|
|
|
|
| 90 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
4,334.80 |
2,898.60 |
|
|
|
|
|
|
|
|
|
|
| 91 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharma Nordic (SE) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
15,221.10 |
11,720.30 |
|
|
|
|
|
|
|
|
|
|
| 92 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Pharma Nordic (SE) |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
5,251.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 93 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
142.10 |
1,392.80 |
|
|
|
|
|
|
|
|
|
|
| 94 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
8,209.20 |
7,178.10 |
|
|
|
|
|
|
|
|
|
|
| 95 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH (Austria) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
430.00 |
550.00 |
|
|
|
|
|
|
|
|
|
|
| 96 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Generics S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
26.80 |
27.10 |
|
|
|
|
|
|
|
|
|
|
| 97 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,420.10 |
3,348.00 |
|
|
|
|
|
|
|
|
|
|
| 98 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Arzneimittel GmbH (Austria) |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
1,022.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 99 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Farmaceuticals Ltda Brazil |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
22.80 |
23.20 |
|
|
|
|
|
|
|
|
|
|
| 100 |
Glenmark Pharmaceuticals s.r.o. |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
114.40 |
402.00 |
|
|
|
|
|
|
|
|
|
|
| 101 |
Glenmark Pharmaceuticals s.r.o. |
|
Glenmark Ukraine LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 102 |
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Glenmark Pharmaceuticals SK SRO, Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 103 |
Glenmark Pharmaceuticals Europe Limited |
|
Viso Farmaceutica S.L.U., Spain |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
37.10 |
53.20 |
|
|
|
|
|
|
|
|
|
|
| 104 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
141.70 |
458.30 |
|
|
|
|
|
|
|
|
|
|
| 105 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharmaceuticals BV |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
104.70 |
134.70 |
|
|
|
|
|
|
|
|
|
|
| 106 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharmaceuticals SP Zoo, Poland |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
5.20 |
3.90 |
|
|
|
|
|
|
|
|
|
|
| 107 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharma Nordic (SE) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
22.80 |
16.10 |
|
|
|
|
|
|
|
|
|
|
| 108 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Impex LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
5.70 |
5.80 |
|
|
|
|
|
|
|
|
|
|
| 109 |
Glenmark Pharmaceuticals Europe Limited |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
196.30 |
286.60 |
|
|
|
|
|
|
|
|
|
|
| 110 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
17.40 |
124.80 |
|
|
|
|
|
|
|
|
|
|
| 111 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
36.90 |
107.00 |
|
|
|
|
|
|
|
|
|
|
| 112 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Generics S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
6.50 |
6.70 |
|
|
|
|
|
|
|
|
|
|
| 113 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharmaceuticals Mexico SA de CV |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
2.80 |
2.90 |
|
|
|
|
|
|
|
|
|
|
| 114 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Farmaceuticals Ltda Brazil |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
46.20 |
47.40 |
|
|
|
|
|
|
|
|
|
|
| 115 |
Glenmark Pharmaceuticals Europe Limited |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Given |
|
- |
|
|
0.00 |
1,434.50 |
1,330.50 |
|
|
|
|
|
|
|
|
|
|
| 116 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Arzneimittel GmbH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
32,420.70 |
17.90 |
|
|
|
|
|
|
|
|
|
|
| 117 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Arzneimittel GmbH (Austria) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
6.10 |
7.30 |
|
|
|
|
|
|
|
|
|
|
| 118 |
Glenmark Pharmaceuticals Europe Limited |
|
Glenmark Pharmaceuticals Distribution s.r.o., Czech Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.00 |
0.80 |
|
|
|
|
|
|
|
|
|
|
| 119 |
Glenmark Arzneimittel GmbH, Germany |
|
Glenmark Arzneimittel GmbH (Austria) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
211.30 |
211.30 |
|
|
|
|
|
|
|
|
|
|
| 120 |
Glenmark Arzneimittel GmbH, Germany |
|
Sintesy Pharma S.r.l. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
82.70 |
150.00 |
|
|
|
|
|
|
|
|
|
|
| 121 |
Glenmark Arzneimittel GmbH - Austria |
|
Glenmark Ukraine LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.00 |
40.00 |
|
|
|
|
|
|
|
|
|
|
| 122 |
Glenmark Pharmaceuticals Kenya Limited |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
12.90 |
19.40 |
|
|
|
|
|
|
|
|
|
|
| 123 |
Glenmark Pharmaceuticals Kenya Limited |
|
Glenmark Pharmaceuticals Egypt S.A.E |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
20.70 |
15.70 |
|
|
|
|
|
|
|
|
|
|
| 124 |
Glenmark Pharmaceuticals South Africa (Pty) Ltd |
|
Glenmark South Africa (Pty) Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan given |
|
- |
|
|
0.00 |
5,197.50 |
5,533.10 |
|
|
|
|
|
|
|
|
|
|
| 125 |
Glenmark Pharmaceuticals South Africa (Pty) Ltd |
|
Glenmark South Africa (Pty) Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Investment |
|
- |
|
|
0.00 |
259.00 |
259.00 |
|
|
|
|
|
|
|
|
|
|
| 126 |
Glenmark Pharmaceuticals Mexico SA de CV |
|
Glenmark Generics S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.00 |
49.10 |
|
|
|
|
|
|
|
|
|
|
| 127 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Mexico SA de CV |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
852.50 |
1,069.30 |
|
|
|
|
|
|
|
|
|
|
| 128 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Ltd. Peru |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
89.10 |
43.90 |
|
|
|
|
|
|
|
|
|
|
| 129 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Generics S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 130 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Ecaudor S.A |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
13.70 |
4.30 |
|
|
|
|
|
|
|
|
|
|
| 131 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Generics S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.00 |
591.00 |
|
|
|
|
|
|
|
|
|
|
| 132 |
Glenmark Farmaceuticals Ltda Brazil |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
1.30 |
|
|
|
|
|
|
|
|
|
|
| 133 |
Glenmark Generics S.A. |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
26.40 |
134.10 |
|
|
|
|
|
|
|
|
|
|
| 134 |
Glenmark Pharmaceuticals Ltd. -Peru |
|
Glenmark Farmaceutica SpA |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan |
|
- |
|
|
0.00 |
26.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 135 |
Glenmark Generics S.A. |
|
Glenmark Pharmaceuticals Venezuela |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
164.40 |
154.50 |
|
|
|
|
|
|
|
|
|
|
| 136 |
Glenmark Generics S.A. |
|
Glenmark Pharmaceuticals Kenya |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
12.00 |
|
|
|
|
|
|
|
|
|
|
| 137 |
Glenmark Generics S.A. |
|
Glenmark Pharmaceuticals Mexico |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
46.80 |
|
|
|
|
|
|
|
|
|
|
| 138 |
Glenmark Generics S.A. |
|
Glenmark Pharmaceuticals Ltd. Peru |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
15.80 |
|
|
|
|
|
|
|
|
|
|
| 139 |
Glenmark Holding S.A. |
|
Glenmark Therapeutics Inc. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
24,817.00 |
24,817.00 |
|
|
|
|
|
|
|
|
|
|
| 140 |
Glenmark Holding S.A. |
|
Glenmark Farmaceutica Ltda, Brazil |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,74,371.20 |
1,74,371.20 |
|
|
|
|
|
|
|
|
|
|
| 141 |
Glenmark Holding S.A. |
|
Investments in GPR&DEL, UK |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 142 |
Glenmark Holding S.A. |
|
Glenmark Specialty SA, Switzerland |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 143 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals S.R.O., Czech |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
71,947.80 |
71,947.80 |
|
|
|
|
|
|
|
|
|
|
| 144 |
Glenmark Holding S.A. |
|
Investments in GPSZ, Poland |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
3,678.30 |
3,678.30 |
|
|
|
|
|
|
|
|
|
|
| 145 |
Glenmark Holding S.A. |
|
Glenmark Specialty SA |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,51,866.90 |
1,51,866.90 |
|
|
|
|
|
|
|
|
|
|
| 146 |
Glenmark Holding S.A. |
|
Viso Farmaceutica, SL |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2.10 |
2.10 |
|
|
|
|
|
|
|
|
|
|
| 147 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Inc.USA |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
3,83,635.40 |
3,83,635.40 |
|
|
|
|
|
|
|
|
|
|
| 148 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Canada Inc |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,075.70 |
1,075.70 |
|
|
|
|
|
|
|
|
|
|
| 149 |
Glenmark Holding S.A. |
|
Glenmark Generics S.A, Argentina |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
8,018.40 |
1,17,179.90 |
1,25,198.30 |
|
|
|
|
|
|
|
|
|
|
| 150 |
Glenmark Holding S.A. |
|
Glenmark Arzneimittel GmBH, Germany |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,068.40 |
1,068.40 |
|
|
|
|
|
|
|
|
|
|
| 151 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals BV Netherlands |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
14.80 |
14.80 |
|
|
|
|
|
|
|
|
|
|
| 152 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Distribution, Czech |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
16,461.20 |
16,461.20 |
|
|
|
|
|
|
|
|
|
|
| 153 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals AB Sweden |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,739.30 |
1,739.30 |
|
|
|
|
|
|
|
|
|
|
| 154 |
Glenmark Holding S.A. |
|
Glenmark Ukraine LLC |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
461.50 |
461.50 |
|
|
|
|
|
|
|
|
|
|
| 155 |
Glenmark Holding S.A. |
|
Investment in Ichnos Sciences Inc |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 156 |
Glenmark Holding S.A. |
|
Preferred Stock in Ichnos Sciences |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
4,12,155.10 |
4,12,155.10 |
|
|
|
|
|
|
|
|
|
|
| 157 |
Glenmark Holding S.A. |
|
Sintesy Pharma S.R.L.,Milano |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,559.50 |
1,559.50 |
|
|
|
|
|
|
|
|
|
|
| 158 |
Glenmark Holding S.A. |
|
Glenmark Farmaceutica Spa., Chile |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
95.10 |
212.50 |
307.60 |
|
|
|
|
|
|
|
|
|
|
| 159 |
Glenmark Holding S.A. |
|
Investments in Glenmark Arzneimittel GmBH, Austria |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
522.50 |
522.50 |
|
|
|
|
|
|
|
|
|
|
| 160 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
2,181.00 |
6,483.00 |
|
|
|
|
|
|
|
|
|
|
| 161 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
4,362.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 162 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Inc. USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
3,102.90 |
3,755.60 |
|
|
|
|
|
|
|
|
|
|
| 163 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Inc. USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
591.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 164 |
Glenmark Specialty S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.00 |
29.20 |
|
|
|
|
|
|
|
|
|
|
| 165 |
Glenmark Specialty S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
31.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 166 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals S.R.O. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
307.40 |
750.70 |
|
|
|
|
|
|
|
|
|
|
| 167 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals S.R.O. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
440.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 168 |
Glenmark Specialty S.A. |
|
Glenmark Arzneimittel GmBH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
166.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 169 |
Glenmark Specialty S.A. |
|
Glenmark Arzneimittel GmBH, Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
253.00 |
422.50 |
|
|
|
|
|
|
|
|
|
|
| 170 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals FZE |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
637.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 171 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals FZE |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
668.30 |
1,308.70 |
|
|
|
|
|
|
|
|
|
|
| 172 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Canada Inc |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
76.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 173 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Canada Inc |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
4.90 |
74.00 |
|
|
|
|
|
|
|
|
|
|
| 174 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals S.R.O. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
32,067.60 |
31,594.30 |
|
|
|
|
|
|
|
|
|
|
| 175 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals S.R.O. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
9,081.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 176 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS KENYA LTD. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
104.50 |
204.20 |
|
|
|
|
|
|
|
|
|
|
| 177 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS KENYA LTD. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
97.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 178 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
373.50 |
748.00 |
|
|
|
|
|
|
|
|
|
|
| 179 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
760.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 180 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Peru S.A |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
581.60 |
713.90 |
|
|
|
|
|
|
|
|
|
|
| 181 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Peru S.A |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
120.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 182 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS ECUADOR S. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
113.90 |
384.60 |
|
|
|
|
|
|
|
|
|
|
| 183 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS ECUADOR S. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
262.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 184 |
Glenmark Specialty S.A. |
|
Glenmark Impex LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
10,678.80 |
15,902.20 |
|
|
|
|
|
|
|
|
|
|
| 185 |
Glenmark Specialty S.A. |
|
Glenmark Impex LLC |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
4,992.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 186 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Inc. USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
56,179.20 |
78,431.90 |
|
|
|
|
|
|
|
|
|
|
| 187 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Inc. USA |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
20,655.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 188 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS MEXICO SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
5,217.70 |
7,568.50 |
|
|
|
|
|
|
|
|
|
|
| 189 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS MEXICO SA |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
2,239.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 190 |
Glenmark Specialty S.A. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
142.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 191 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals FZE |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
447.40 |
815.70 |
|
|
|
|
|
|
|
|
|
|
| 192 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals FZE |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
360.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 193 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,274.00 |
1,473.40 |
|
|
|
|
|
|
|
|
|
|
| 194 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
814.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 195 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceutical Colombia S. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
426.50 |
551.80 |
|
|
|
|
|
|
|
|
|
|
| 196 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceutical Colombia S. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
112.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 197 |
Glenmark Specialty S.A. |
|
GLENMARK PHILIPPINES INC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
7.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 198 |
Glenmark Specialty S.A. |
|
GLENMARK PHILIPPINES INC |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
8.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 199 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS (THAILAND) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
261.60 |
269.70 |
|
|
|
|
|
|
|
|
|
|
| 200 |
Glenmark Specialty S.A. |
|
GLENMARK PHARMACEUTICALS (THAILAND) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
268.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 201 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Australia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
851.30 |
843.30 |
|
|
|
|
|
|
|
|
|
|
| 202 |
Glenmark Specialty S.A. |
|
Glenmark Pharmaceuticals Australia |
|
Wholly Owned Subsidiary |
Any other transaction |
Interest Income |
|
- |
|
|
17.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 203 |
Glenmark Specialty S.A. |
|
GLENMARK FARMACĆUTICA LTDA |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
639.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 204 |
Glenmark Specialty S.A. |
|
GLENMARK FARMACĆUTICA LTDA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
633.60 |
|
|
|
|
|
|
|
|
|
|
| 205 |
Glenmark Specialty S.A. |
|
Glenmark Therapeutics Inc, |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
359.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 206 |
Glenmark Specialty S.A. |
|
Glenmark Therapeutics Inc, |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.00 |
364.50 |
|
|
|
|
|
|
|
|
|
|
| 207 |
Glenmark Specialty S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
37.30 |
60.60 |
|
|
|
|
|
|
|
|
|
|
| 208 |
Glenmark Specialty S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Other Income |
|
- |
|
|
24.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 209 |
Glenmark Holding S.A. |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
1,23,140.80 |
1,23,899.60 |
|
|
|
|
Loan |
4.500 |
5 |
Unsecured |
Business Purpose |
|
| 210 |
Glenmark Holding S.A. |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
2,888.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 211 |
Glenmark Holding S.A. |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Given |
|
- |
|
|
14,276.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 212 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Sp Z.o.o |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
13.70 |
0.00 |
|
|
|
|
Loan |
5.00 |
5 |
Unsecured |
Business Purpose |
|
| 213 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
4,32,080.40 |
5,49,545.80 |
|
|
|
|
Loan |
5.00 |
3 |
Unsecured |
Business Purpose |
|
| 214 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Inc. |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
16,477.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 215 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Given |
|
- |
|
|
2,29,608.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 216 |
Glenmark Holding S.A. |
|
GLENMARK PHARMACEUTICALS MEXICO SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
1,829.70 |
1,773.50 |
|
|
|
|
Loan |
5.2500 |
3 |
Unsecured |
Business Purpose |
|
| 217 |
Glenmark Holding S.A. |
|
GLENMARK PHARMACEUTICALS MEXICO SA |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
49.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 218 |
Glenmark Holding S.A. |
|
GLENMARK PHARMACEUTICALS KENYA LTD. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
214.00 |
0.00 |
|
|
|
|
Loan |
5.00 |
3 |
Unsecured |
Business Purpose |
|
| 219 |
Glenmark Holding S.A. |
|
GLENMARK PHARMACEUTICALS KENYA LTD. |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
4.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 220 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
1,876.60 |
1,844.30 |
|
|
|
|
Loan |
5.2500 |
3 |
Unsecured |
Business Purpose |
|
| 221 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Colombia |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
50.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 222 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Peru S.A |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
(0.10) |
(0.10) |
|
|
|
|
Loan |
5.00 |
3 |
Unsecured |
Business Purpose |
|
| 223 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Ecuador |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Receivable |
|
- |
|
|
0.00 |
1,876.60 |
1,389.20 |
|
|
|
|
Loan |
5.400 |
3 |
Unsecured |
Business Purpose |
|
| 224 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Ecuador |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
48.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 225 |
Glenmark Holding S.A. |
|
Glenmark FarmacĆŖutica Ltda |
|
Wholly Owned Subsidiary |
Any other transaction |
Interest Receivable |
|
- |
|
|
0.00 |
48.40 |
49.40 |
|
|
|
|
|
|
|
|
|
|
| 226 |
Glenmark Holding S.A. |
|
Ichnos Glenmark Innovation Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Dividend Receivable |
|
- |
|
|
0.00 |
10,172.40 |
14,079.50 |
|
|
|
|
|
|
|
|
|
|
| 227 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
12,238.00 |
22,658.20 |
|
|
|
|
Loan |
5.2100 |
1 |
Unsecured |
Business Purpose |
|
| 228 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Interest paid |
|
|
- |
|
|
312.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 229 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
37,096.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 230 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals B.V. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
24,341.20 |
26,968.90 |
|
|
|
|
Loan |
3.3200 |
1 |
Unsecured |
Business Purpose |
|
| 231 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals B.V. |
|
Wholly Owned Subsidiary |
Interest paid |
|
|
- |
|
|
398.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 232 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals B.V. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
3,345.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 233 |
Glenmark Holding S.A. |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense Payable |
|
- |
|
|
0.00 |
142.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 234 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
14,074.70 |
14,370.80 |
|
|
|
|
Loan |
4.00 |
0.5 |
Unsecured |
Business Purpose |
|
| 235 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
1,57,431.20 |
1,37,805.10 |
|
|
|
|
Loan |
4.00 |
3 |
Unsecured |
Business Purpose |
|
| 236 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
4,814.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 237 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
3,183.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 238 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense Payable |
|
- |
|
|
0.00 |
0.00 |
8.20 |
|
|
|
|
|
|
|
|
|
|
| 239 |
Glenmark Holding S.A. |
|
IGI Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Expense |
|
- |
|
|
8.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 240 |
Glenmark Holding S.A. |
|
Ichnos Glenmark Innovation Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
1,87,048.40 |
63,788.00 |
|
|
|
|
Loan |
4.2500 |
4.5 |
Unsecured |
Business purpose |
|
| 241 |
Glenmark Holding S.A. |
|
Ichnos Glenmark Innovation Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
28.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 242 |
Glenmark Holding S.A. |
|
Ichnos Glenmark Innovation Inc. |
|
Wholly Owned Subsidiary |
Interest paid |
|
|
- |
|
|
2,126.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 243 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
0.00 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 244 |
Glenmark Holding S.A. |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 245 |
Glenmark Holding S.A. |
|
Glenmark Arzeneimittel Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Payable |
|
- |
|
|
0.00 |
37,081.30 |
59,736.90 |
|
|
|
|
Loan |
3.3200 |
1 |
Unsecured |
Business purpose |
|
| 246 |
Glenmark Holding S.A. |
|
Glenmark Arzeneimittel Germany |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Taken |
|
- |
|
|
26,525.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 247 |
Glenmark Holding S.A. |
|
Glenmark Arzeneimittel Germany |
|
Wholly Owned Subsidiary |
Interest paid |
|
|
- |
|
|
665.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 248 |
Ichnos Glenmark Innovation Inc. |
|
Ichnos Glenmark innovation Therapeutics SA |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
85,032.00 |
85,032.00 |
|
|
|
|
|
|
|
|
|
|
| 249 |
Ichnos Glenmark Innovation Inc. |
|
Ichnos Glenmark innovation Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Other Income/ Receivable |
|
- |
|
|
5,393.70 |
24,832.70 |
24,018.40 |
|
|
|
|
|
|
|
|
|
|
| 250 |
Ichnos Glenmark Innovation Inc. |
|
Ichnos Glenmark innovation Therapeutics SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses reimbursed |
|
- |
|
|
2.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 251 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Issue of Share capital |
|
- |
|
|
0.00 |
829.20 |
829.20 |
|
|
|
|
|
|
|
|
|
|
| 252 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Issue of Share Prenium |
|
- |
|
|
0.00 |
4,30,407.60 |
4,30,407.60 |
|
|
|
|
|
|
|
|
|
|
| 253 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Dividend Payable |
|
- |
|
|
0.00 |
10,174.50 |
14,096.30 |
|
|
|
|
|
|
|
|
|
|
| 254 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Dividend declared |
|
- |
|
|
1,30,230.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 255 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
2,139.50 |
0.00 |
0.00 |
|
|
|
|
Loan |
4.00 |
Long Term |
Unsecured |
Business Purpose |
|
| 256 |
Ichnos Glenmark Innovation Inc. |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
loan Given |
|
- |
|
|
0.00 |
1,87,086.00 |
63,864.20 |
|
|
|
|
|
|
|
|
|
|
| 257 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Loan Given |
|
- |
|
|
0.00 |
1,71,547.50 |
1,52,355.00 |
|
|
|
|
|
|
|
|
|
|
| 258 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
3,174.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 259 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Speciality S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
creditors |
|
- |
|
|
0.00 |
37.30 |
60.90 |
|
|
|
|
|
|
|
|
|
|
| 260 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Speciality S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
debtors |
|
- |
|
|
0.00 |
0.00 |
28.70 |
|
|
|
|
|
|
|
|
|
|
| 261 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Pharmaceuticals Inc USA |
|
Wholly Owned Subsidiary |
Any other transaction |
debtors |
|
- |
|
|
0.00 |
27.40 |
27.40 |
|
|
|
|
|
|
|
|
|
|
| 262 |
Ichnos Glenmark innovation Therapeutics SA |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
8.50 |
0.00 |
8.20 |
|
|
|
|
|
|
|
|
|
|
| 263 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Farmaceutica Ltda., Brazil |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
9,026.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 264 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Australia) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
777.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 265 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Phillipines Inc., Philippines |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,298.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 266 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Impex L.L.C., Russia |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
27,962.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 267 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd., South Africa |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1,919.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 268 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Peru SAC., Peru |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
263.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 269 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Thailand) Co. Ltd., Thailand |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
175.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 270 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd, Kenya |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,436.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 271 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Colombia Ltda., Colombia |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
957.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 272 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Mexico, S.A. DE C.V., Mexico |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
4,260.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 273 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd., Malaysia |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,722.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 274 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Inc., USA |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
64,246.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 275 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals s.r.o., Czech Republic |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
17,365.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 276 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Europe Ltd. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
7,567.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 277 |
Glenmark Pharmaceuticals Limited |
|
GLENMARK PHARMACEUTICALS ECUADOR S. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
783.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 278 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Therapeutics Inc., USA |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
563.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 279 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Ukrain LLC |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
2,378.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 280 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Canada Inc., Canada |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,260.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 281 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
12.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 282 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Ltd(goods Sales) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
6,968.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 283 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Ltd(service sales) |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
6,477.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 284 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Sale of goods or services |
|
|
- |
|
|
30,845.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 285 |
Glenmark Pharmaceuticals Limited |
|
Ichnos Sciences SA |
|
Wholly Owned Subsidiary |
Any other transaction |
Other operating income |
|
- |
|
|
881.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 286 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Other operating income |
|
- |
|
|
4,362.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 287 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Other operating income |
|
- |
|
|
167.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 288 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Other operating income |
|
- |
|
|
872.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 289 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Sale of fixed assets |
|
|
- |
|
|
95.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 290 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Sale of fixed assets |
|
|
- |
|
|
212.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 291 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Sale of Intangibles |
|
- |
|
|
22,300.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 292 |
Glenmark Pharmaceuticals Limited |
|
Glenmark G SA., Argentina |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
231.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 293 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Inc., USA |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
40,909.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 294 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals FZE., United Arab Emirates(Service) |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
4,456.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 295 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Europe Ltd |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
859.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 296 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Impex L.L.C., Russia |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
4,202.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 297 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals s.r.o., Czech Republic |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
37.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 298 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals s.r.o., Czech Republic(Service) |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
124.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 299 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Canada Inc., Canada |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
41.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 300 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
8,805.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 301 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd, Kenya |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
37.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 302 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Singapore Pte Ltd |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
239.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 303 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Ukraine LLC (Service) |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
168.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 304 |
Glenmark Pharmaceuticals Limited |
|
Ichnos Sciences S.A. |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
(3,001.30) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 305 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
372.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 306 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Ltd(purchase of goods) |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
236.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 307 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Ltd ( royalty) |
|
Wholly Owned Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
257.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 308 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Inc., USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Purchase of Tangibles/Capex |
|
- |
|
|
37.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 309 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Holding S.A |
|
Wholly Owned Subsidiary |
Loan |
|
|
- |
|
|
9,175.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 310 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Loan |
|
|
- |
|
|
2,103.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 311 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Holding S.A., Switzerland |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
8,352.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 312 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd, Kenya |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
85.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 313 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Thailand) Co Ltd |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
3.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 314 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmacuticals Australia |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
37.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 315 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
202.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 316 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Limited |
|
Wholly Owned Subsidiary |
Interest received |
|
|
- |
|
|
41.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 317 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Holding S.A., Switzerland |
|
Wholly Owned Subsidiary |
Any other transaction |
Other income |
|
- |
|
|
15.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 318 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals s.r.o., Czech Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Other income |
|
- |
|
|
0.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 319 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Foundation |
|
Other related party |
Any other transaction |
CSR Contribution |
3,000.00 |
- |
|
|
400.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 320 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Aquatic Foundation |
|
Other related party |
Any other transaction |
CSR Contribution |
750.00 |
- |
|
|
378.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 321 |
Glenmark Pharmaceuticals Limited |
|
Mr. Glenn Saldanha |
|
Chairman & Managing Director (Promoter) |
Remuneration |
|
|
- |
|
|
1,125.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 322 |
Glenmark Pharmaceuticals Limited |
|
Mrs. Cherylann Pinto |
|
Executive Director (Promoter) |
Remuneration |
|
|
- |
|
|
233.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 323 |
Glenmark Pharmaceuticals Limited |
|
Mrs. Blanche Saldanha |
|
Non Executive Director (Promoter) |
Any other transaction |
Sitting Fees |
|
- |
|
|
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 324 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Arzneimittel GmbH |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
2,519.60 |
2,538.80 |
|
|
|
|
|
|
|
|
|
|
| 325 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Farmaceutica Ltda., Brazil |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
13,970.40 |
21,127.20 |
|
|
|
|
|
|
|
|
|
|
| 326 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Philippines Inc., Philippines |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,666.90 |
4,690.30 |
|
|
|
|
|
|
|
|
|
|
| 327 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Therapeutics Inc., USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,836.40 |
1,750.30 |
|
|
|
|
|
|
|
|
|
|
| 328 |
Glenmark Pharmaceuticals Limited |
|
IGI Therapeutics SA (Formerly known as Ichnos Sciences SA) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,343.50 |
7,340.50 |
|
|
|
|
|
|
|
|
|
|
| 329 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Holding S.A., Switzerland(Loan given) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
5,48,309.00 |
5,77,993.20 |
|
|
|
|
|
|
|
|
|
|
| 330 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Nigeria) Ltd., Nigeria |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,314.10 |
3,314.10 |
|
|
|
|
|
|
|
|
|
|
| 331 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Nigeria) Ltd., Nigeria(Loan given) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,152.60 |
1,152.60 |
|
|
|
|
|
|
|
|
|
|
| 332 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Impex L.L.C., Russia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
7,402.00 |
14,221.70 |
|
|
|
|
|
|
|
|
|
|
| 333 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals South Africa (Pty) Ltd., South Africa |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
6,143.10 |
5,250.00 |
|
|
|
|
|
|
|
|
|
|
| 334 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals FZE., United Arab Emirates |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
8,615.90 |
(7,155.40) |
|
|
|
|
|
|
|
|
|
|
| 335 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Generics SA., Argentina |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
568.80 |
1,423.20 |
|
|
|
|
|
|
|
|
|
|
| 336 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Venezuela., C.A , Venezuela |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
15,582.00 |
15,582.00 |
|
|
|
|
|
|
|
|
|
|
| 337 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Malaysia Sdn.Bhd., Malaysia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
3,328.90 |
3,591.30 |
|
|
|
|
|
|
|
|
|
|
| 338 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Peru SAC., Peru |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
219.60 |
489.50 |
|
|
|
|
|
|
|
|
|
|
| 339 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Europe Ltd U.K. (Glenmark Generics (Europe) Ltd., U.K.) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
2,016.90 |
34,418.20 |
|
|
|
|
|
|
|
|
|
|
| 340 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Inc., USA |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
71,914.50 |
42,822.10 |
|
|
|
|
|
|
|
|
|
|
| 341 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals s.r.o., Czech Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
19,623.50 |
10,070.80 |
|
|
|
|
|
|
|
|
|
|
| 342 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals SK, s.r.o., Slovak Republic |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
0.10 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 343 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals SPĀ z.o.o. |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
1.60 |
1.60 |
|
|
|
|
|
|
|
|
|
|
| 344 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Thailand) Co. Ltd., Thailand |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
432.10 |
237.40 |
|
|
|
|
|
|
|
|
|
|
| 345 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Thailand) Co. Ltd., Thailand (Loan given) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
196.30 |
204.50 |
|
|
|
|
|
|
|
|
|
|
| 346 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Uruguay S.A., Uruguay |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
9,328.70 |
9,534.40 |
|
|
|
|
|
|
|
|
|
|
| 347 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Colombia Ltda., Colombia |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,624.10 |
2,463.10 |
|
|
|
|
|
|
|
|
|
|
| 348 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd; Kenya |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
18,951.30 |
18,925.70 |
|
|
|
|
|
|
|
|
|
|
| 349 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd; Kenya (Loan Given) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,810.20 |
2,102.20 |
|
|
|
|
|
|
|
|
|
|
| 350 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Mexico S.A. DE C.V. Mexico |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
8,304.20 |
13,826.80 |
|
|
|
|
|
|
|
|
|
|
| 351 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Egypt S.A.E., Egypt(Loan given) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,080.30 |
1,167.00 |
|
|
|
|
|
|
|
|
|
|
| 352 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Canada Inc. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
7,229.40 |
5,223.80 |
|
|
|
|
|
|
|
|
|
|
| 353 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Specialty S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
26,921.20 |
57,846.80 |
|
|
|
|
|
|
|
|
|
|
| 354 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Ukraine LLC |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
4,676.70 |
4,114.80 |
|
|
|
|
|
|
|
|
|
|
| 355 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Ecuador S.A. |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
726.70 |
1,335.90 |
|
|
|
|
|
|
|
|
|
|
| 356 |
Glenmark Pharmaceuticals Limited |
|
GLENMARK PHARMACEUTICALS SINGAPORE |
|
Wholly Owned Subsidiary |
Any other transaction |
Payable |
|
- |
|
|
0.00 |
804.80 |
759.60 |
|
|
|
|
|
|
|
|
|
|
| 357 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Australia) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
758.70 |
1,040.80 |
|
|
|
|
|
|
|
|
|
|
| 358 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Australia)(loan) |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
1,505.20 |
1,593.30 |
|
|
|
|
|
|
|
|
|
|
| 359 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
28,051.80 |
21,932.40 |
|
|
|
|
|
|
|
|
|
|
| 360 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Ltd |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
4,082.40 |
32,567.20 |
|
|
|
|
|
|
|
|
|
|
| 361 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Mexico S.A. DE C.V. Mexico |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
917.10 |
917.10 |
|
|
|
|
|
|
|
|
|
|
| 362 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Peru SAC., Peru |
|
Wholly Owned Subsidiary |
Any other transaction |
Receivable |
|
- |
|
|
0.00 |
0.10 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 363 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Impex L.L.C |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
14,356.10 |
14,356.10 |
|
|
|
|
|
|
|
|
|
|
| 364 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Philippines Inc. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,167.00 |
1,167.00 |
|
|
|
|
|
|
|
|
|
|
| 365 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Malaysia Sdn Bhd |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
977.20 |
977.20 |
|
|
|
|
|
|
|
|
|
|
| 366 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Holding S.A. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
14,32,317.50 |
14,32,317.50 |
|
|
|
|
|
|
|
|
|
|
| 367 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Australia) Pty Ltd |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,017.20 |
1,017.20 |
|
|
|
|
|
|
|
|
|
|
| 368 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Egypt S.A.E. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
6,342.70 |
6,342.70 |
|
|
|
|
|
|
|
|
|
|
| 369 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals FZE |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
129.20 |
129.20 |
|
|
|
|
|
|
|
|
|
|
| 370 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Dominicana SRL |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2.30 |
2.30 |
|
|
|
|
|
|
|
|
|
|
| 371 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Kenya Ltd |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
971.80 |
971.80 |
|
|
|
|
|
|
|
|
|
|
| 372 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Colombia SAS, Colombia |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
5,774.70 |
5,774.70 |
|
|
|
|
|
|
|
|
|
|
| 373 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Peru SAC |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
8,277.90 |
8,277.90 |
|
|
|
|
|
|
|
|
|
|
| 374 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Mexico, S.A. DE C.V. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
16,952.90 |
16,952.90 |
|
|
|
|
|
|
|
|
|
|
| 375 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Europe Ltd., U.K. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
5,782.30 |
5,782.30 |
|
|
|
|
|
|
|
|
|
|
| 376 |
Glenmark Pharmaceuticals Limited |
|
Glenmark South Africa (pty) Ltd |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
10,442.00 |
10,442.00 |
|
|
|
|
|
|
|
|
|
|
| 377 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Uruguay S.A. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
7,745.30 |
7,745.30 |
|
|
|
|
|
|
|
|
|
|
| 378 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals (Thailand) Co. Ltd |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
37.20 |
37.20 |
|
|
|
|
|
|
|
|
|
|
| 379 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Ecuador S.A. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2,454.90 |
2,454.90 |
|
|
|
|
|
|
|
|
|
|
| 380 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Pharmaceuticals Singapore Pte. Ltd. |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
327.30 |
327.30 |
|
|
|
|
|
|
|
|
|
|
| 381 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Healthcare Limited |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
905.00 |
905.00 |
|
|
|
|
|
|
|
|
|
|
| 382 |
Glenmark Pharmaceuticals Limited |
|
Glenmark Consumer Care Limited |
|
Wholly Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
5.00 |
5.00 |
|
|
|
|
|
|
|
|
|
|
|
Total value of transaction during the reporting period |
9,35,888.90 |
|
|